Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00508235 · ClinicalTrials.gov registry record
Quality of Friendships in Children With Neurofibromatosis
A clinical trial of Neurofibromatosis, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 61
- Enrollment target
- 1
- Study location
NCT00508235 is a study of Neurofibromatosis that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 61 participants, below the 117-participant average among 5 other Neurofibromatosis trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00508235, a study of Neurofibromatosis, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to determine if children with a higher disease severity have lower quality friendships than children who are less severely affected and children who are unaffected. Researchers will test the hypothesis that the quality of friendships is inversely related to their disease severity. Specific Aims: 1. To use the FQQ to determine if the quality of friendships in children with NF1 is lower than the quality of friendships in unaffected children. 2. To use a disease severity scale and the FQQ to determine if children who are less severely affected have higher friendship qualities than children who are more severely affected.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
Study Locations (1)
Texas
- U.T.M.D. Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00508235
The ClinicalTrials.gov registry entry for NCT00508235 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 117-participant average among 5 other Neurofibromatosis trials with a reported enrollment target (48% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neurofibromatosis appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.
NCT00508235 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00508235 about?
NCT00508235 is a clinical study titled "Quality of Friendships in Children With Neurofibromatosis". The aim of this study is to determine if children with a higher disease severity have lower quality friendships than children who are less severely affected and children who are unaffected. Researchers will test the hypothesis that the quality of friendships is inversely related to their disease sev...
What is the current status of trial NCT00508235?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2004-12. Estimated completion is 2009-07.
What conditions does trial NCT00508235 study?
This clinical trial studies the following conditions: Neurofibromatosis.
What interventions are being tested in trial NCT00508235?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00508235?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00508235 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurofibromatosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Natural History Study of Patients With Neurofibromatosis Type 2
RECRUITING
-
Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
RECRUITING · Phase 1
-
Validating Pain Scales in Children and Young Adults
COMPLETED
-
Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1
COMPLETED · Phase 1
-
Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.